After obtaining her PhD from the University of London in 2001, Claire Davies performed her postdoctoral work at the William Harvey Research Institute (WHRI) at Bart’s and The London, Queen Mary’s School of Medicine and Dentistry and Joslin Diabetes Center, Harvard Medical School, Boston. Over the last 14 years, Dr.
Davies has led analytical and CMC teams in product development and analytical method development and validation. Currently, Dr. Davies leads Bioanalytics, a group responsible for developing methods and strategies to support process development, product characterization and release and stability testing for therapeutic proteins and gene therapy products in preclinical and clinical development.
Read More